New Year Bumper Sale @ Rs. 1 X
Symbiva 200 Capsule is a commercial drug that is prescribed in the form of Capsule. It is typically used for the treatment of Asthma. The alternative uses of Symbiva 200 Capsule have also been explained below.
The optimal dosage of Symbiva 200 Capsule is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Symbiva 200 Capsule also has some side effects, the most common being Nasopharyngitis, Headache, Back Pain. Apart from the aforementioned side effects, Symbiva 200 Capsule can also lead to other problems, which have been listed below. Such side effects of Symbiva 200 Capsule normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Symbiva 200 Capsule's effect during pregnancy is Moderate and Moderate while nursing. Further, the section on Symbiva 200 Capsule related warnings talks about Symbiva 200 Capsule's effects on the liver, heart and kidney.
Some other conditions that can be affected by Symbiva 200 Capsule are listed in the contraindications section below.
Drug reaction of Symbiva 200 Capsule with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Symbiva 200 Capsule is safe while driving, and is is addictive in nature.
Symbiva 200 Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Symbiva 200 Capsule safe for pregnant women?
Pregnant women may experience moderate side effects from Symbiva. It is best to stop taking Symbiva immediately and inform your doctor if you notice any discomfort.
Is the use of Symbiva 200 Capsule safe during breastfeeding?
Symbiva can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Symbiva 200 Capsule on the Kidneys?
There are no side effects of Symbiva on the kidneys.
What is the effect of Symbiva 200 Capsule on the Liver?
Symbiva does not damage the liver.
What is the effect of Symbiva 200 Capsule on the Heart?
Symbiva is rarely harmful for the heart.
Symbiva 200 Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Symbiva 200 Capsule unless your doctor advises you to do so -
Is this Symbiva 200 Capsule habit forming or addictive?
No, you will not get addicted to Symbiva 200 Capsule.
Is it safe to drive or operate heavy machinery when consuming?
Symbiva 200 Capsule will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Symbiva 200 Capsule should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Symbiva 200 Capsule in mental disorders is not effective.
Interaction between Food and Symbiva 200 Capsule
Taking Symbiva 200 Capsule with food is safe.
Interaction between Alcohol and Symbiva 200 Capsule
Taking Symbiva 200 Capsule with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
Product Description [Internet]: SYMBICORT. AstraZeneca